Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Lisdene
Active Ingredient(s): Lisinopril (dihydrate) 10mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Delta Limited, Hafnarfjordur, Iceland
Product: Lisdene
Active Ingredient(s): Lisinopril (dihydrate) 20mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Delta Limited, Hafnarfjordur, Iceland
Product: Lisdene
Active Ingredient(s): Lisinopril (dihydrate) 5mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Delta Limited, Hafnarfjordur, Iceland
Dated this 7th day of November 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).